- Home
- SSP vs CRVO Comparison
SSP vs CRVO Comparison
Compare SSP & CRVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSP
- CRVO
- Stock Information
- Founded
- SSP 1878
- CRVO 2001
- Country
- SSP United States
- CRVO United States
- Employees
- SSP N/A
- CRVO N/A
- Industry
- SSP Broadcasting
- CRVO Biotechnology: Pharmaceutical Preparations
- Sector
- SSP Industrials
- CRVO Health Care
- Exchange
- SSP Nasdaq
- CRVO Nasdaq
- Market Cap
- SSP 173.3M
- CRVO 160.4M
- IPO Year
- SSP 1988
- CRVO N/A
- Fundamental
- Price
- SSP $1.93
- CRVO $17.44
- Analyst Decision
- SSP Buy
- CRVO Strong Buy
- Analyst Count
- SSP 2
- CRVO 4
- Target Price
- SSP $7.75
- CRVO $58.25
- AVG Volume (30 Days)
- SSP 564.8K
- CRVO 68.8K
- Earning Date
- SSP 11-01-2024
- CRVO 08-09-2024
- Dividend Yield
- SSP N/A
- CRVO N/A
- EPS Growth
- SSP N/A
- CRVO N/A
- EPS
- SSP N/A
- CRVO N/A
- Revenue
- SSP $2,317,391,000.00
- CRVO $9,653,281.00
- Revenue This Year
- SSP $8.99
- CRVO $47.04
- Revenue Next Year
- SSP N/A
- CRVO N/A
- P/E Ratio
- SSP N/A
- CRVO N/A
- Revenue Growth
- SSP N/A
- CRVO 585.67
- 52 Week Low
- SSP $1.68
- CRVO $4.28
- 52 Week High
- SSP $9.35
- CRVO $26.38
- Technical
- Relative Strength Index (RSI)
- SSP 40.78
- CRVO 55.34
- Support Level
- SSP $1.68
- CRVO $14.83
- Resistance Level
- SSP $2.19
- CRVO $17.43
- Average True Range (ATR)
- SSP 0.13
- CRVO 1.76
- MACD
- SSP 0.03
- CRVO 0.04
- Stochastic Oscillator
- SSP 40.48
- CRVO 73.22
About SSP E.W. Scripps Company (The)
The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.
About CRVO CervoMed Inc.
CervoMed Inc is a clinical-stage biotechnology company. It is focused on developing treatments for age-related neurologic disorders. The company's product candidate, Neflamapimod has the potential to treat and improve synaptic dysfunction, the reversible aspect of the underlying disease processes in DLB and certain other neurological disorders.